{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:13:01Z","timestamp":1790223181971,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ajog.2017.01.036","type":"journal-article","created":{"date-parts":[[2017,1,29]],"date-time":"2017-01-29T05:32:54Z","timestamp":1485667974000},"page":"586.e1-586.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food\u00a0and\u00a0Drug Administration\u2013approved duration"],"prefix":"10.1016","volume":"216","author":[{"given":"Colleen","family":"McNicholas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Swor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey F.","family":"Peipert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"173","key":"10.1016\/j.ajog.2017.01.036_bib1","first-page":"1","article-title":"Current contraceptive status among women aged 15-44: United States, 2011-2013","author":"Daniels","year":"2014","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ajog.2017.01.036_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/AOG.0000000000000690","article-title":"Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the US Food and Drug Administration\u2013approved duration","volume":"125","author":"McNicholas","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.01.036_bib3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0140-6736(90)92050-R","article-title":"Long-term use of copper intrauterine devices","volume":"336","author":"Sivin","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2017.01.036_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/13625189809051409","article-title":"A\u00a04-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand","volume":"3","author":"Kiriwat","year":"1998","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2017.01.036_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.contraception.2014.02.011","article-title":"Extended use of the intrauterine device: a literature review and recommendations for clinical practice","volume":"89","author":"Wu","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.01.036_bib6","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/humrep\/dew222","article-title":"Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant","volume":"31","author":"Ali","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.01.036_bib7","unstructured":"World Health Organization. Global database on body mass index. Available from: http:\/\/apps.who.int\/bmi\/index.jsp?introPage=intro_3.html. Accessed March 10, 2017."},{"key":"10.1016\/j.ajog.2017.01.036_bib8","doi-asserted-by":"crossref","first-page":"39.e1","DOI":"10.1016\/j.ajog.2012.04.022","article-title":"Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women","volume":"207","author":"Westhoff","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.01.036_bib9","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.fertnstert.2011.08.019","article-title":"Characteristics of users of intrauterine devices and other reversible contraceptive methods in the United States","volume":"96","author":"Xu","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.01.036_bib10","doi-asserted-by":"crossref","first-page":"110.e1","DOI":"10.1016\/j.ajog.2012.05.002","article-title":"Pharmacokinetics of the etonogestrel contraceptive implant in obese women","volume":"207","author":"Mornar","year":"2012","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817301710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817301710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:14:13Z","timestamp":1757589253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937817301710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0002937817301710"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.01.036","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727259134.793547605","asserted-by":"object"}]},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food\u00a0and\u00a0Drug Administration\u2013approved duration","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.01.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}